Boston. San Francisco. Beijing? The global biotech industry has long been concentrated in a handful of cities. But which emerging hubs could become dominant forces in biotech in the decades ahead? In this week’s episode of “The Top Line,” Fierce Biotech’s Darren Incorvaia and Will Maddox discuss a new Fierce special report identifying five cities with the potential to become major forces in the global biotech industry. Did your favorite city make the cut? Listen to find out. To learn more about the topics in this episode: Top emerging biotech hubs in 2026 As US lawmakers increase scrutiny of Chinese trials, industry fears ‘huge distraction and expense’ British biotech VC funding shows ‘signs of recovery,’ but IPO rebound yet to materialize Could Basel be the next Boston? How the Swiss biotech hub is quietly raising its game See omnystudio.com/listener for privacy information.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Top Line
GSK’s first lung cancer approval, a new IPO path and more
Why modern clinical trials need a finance-first strategy (Sponsored)
Decision readiness is the next AI advantage (Sponsored)
A $10B deal, China trial scrutiny and highlights from ADA 2026
Get summaries like this every morning.
Free AI-powered recaps of The Top Line and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.